Literature DB >> 12192408

Molecular evolution of FOXP2, a gene involved in speech and language.

Wolfgang Enard1, Molly Przeworski, Simon E Fisher, Cecilia S L Lai, Victor Wiebe, Takashi Kitano, Anthony P Monaco, Svante Pääbo.   

Abstract

Language is a uniquely human trait likely to have been a prerequisite for the development of human culture. The ability to develop articulate speech relies on capabilities, such as fine control of the larynx and mouth, that are absent in chimpanzees and other great apes. FOXP2 is the first gene relevant to the human ability to develop language. A point mutation in FOXP2 co-segregates with a disorder in a family in which half of the members have severe articulation difficulties accompanied by linguistic and grammatical impairment. This gene is disrupted by translocation in an unrelated individual who has a similar disorder. Thus, two functional copies of FOXP2 seem to be required for acquisition of normal spoken language. We sequenced the complementary DNAs that encode the FOXP2 protein in the chimpanzee, gorilla, orang-utan, rhesus macaque and mouse, and compared them with the human cDNA. We also investigated intraspecific variation of the human FOXP2 gene. Here we show that human FOXP2 contains changes in amino-acid coding and a pattern of nucleotide polymorphism, which strongly suggest that this gene has been the target of selection during recent human evolution.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192408     DOI: 10.1038/nature01025

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  315 in total

1.  Species-specific exon loss in human transcriptomes.

Authors:  Jinkai Wang; Zhi-xiang Lu; Collin J Tokheim; Sara E Miller; Yi Xing
Journal:  Mol Biol Evol       Date:  2014-11-14       Impact factor: 16.240

2.  Genomics. Behavior and the dynamic genome.

Authors:  Alison M Bell; Gene E Robinson
Journal:  Science       Date:  2011-06-03       Impact factor: 47.728

3.  Adaptive evolution of MRG, a neuron-specific gene family implicated in nociception.

Authors:  Sun Shim Choi; Bruce T Lahn
Journal:  Genome Res       Date:  2003-10       Impact factor: 9.043

4.  Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions.

Authors:  Shanru Li; Joel Weidenfeld; Edward E Morrisey
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

5.  Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain.

Authors:  Elizabeth Spiteri; Genevieve Konopka; Giovanni Coppola; Jamee Bomar; Michael Oldham; Jing Ou; Sonja C Vernes; Simon E Fisher; Bing Ren; Daniel H Geschwind
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

Review 6.  Enhancing our brains: Genomic mechanisms underlying cortical evolution.

Authors:  Caitlyn Mitchell; Debra L Silver
Journal:  Semin Cell Dev Biol       Date:  2017-08-31       Impact factor: 7.727

7.  An ORFeome-based analysis of human transcription factor genes and the construction of a microarray to interrogate their expression.

Authors:  David N Messina; Jarret Glasscock; Warren Gish; Michael Lovett
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

Review 8.  Human brain evolution: transcripts, metabolites and their regulators.

Authors:  Mehmet Somel; Xiling Liu; Philipp Khaitovich
Journal:  Nat Rev Neurosci       Date:  2013-01-17       Impact factor: 34.870

9.  Reconstructing large regions of an ancestral mammalian genome in silico.

Authors:  Mathieu Blanchette; Eric D Green; Webb Miller; David Haussler
Journal:  Genome Res       Date:  2004-12       Impact factor: 9.043

10.  A fast-evolving human NPAS3 enhancer gained reporter expression in the developing forebrain of transgenic mice.

Authors:  Gretel B Kamm; Rodrigo López-Leal; Juan R Lorenzo; Lucía F Franchini
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-11-11       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.